New alternatives for the pharmacotherapy of anxiety disorders

By den Boer J.A.   van Megen H.J.G.M.   Westenberg H.G.M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 211-212

Elsevier

Access to resources Recommend Favorite

Pharmacotherapy of Anxiety and Repetitive Behaviors in Autism Spectrum Disorders

By  

Child and Adolescent Psychopharmacology News, Vol. 19, Iss. 1, 2014-02 ,pp. : 5-9

Guilford Publications Inc

Access to resources Recommend Favorite

Pharmacotherapy of Comorbid Mood, Anxiety, and Substance Use Disorders

By Brady Kathleen   Verduin Marcia  

Substance Use & Misuse, Vol. 40, Iss. 13-14, 2005-12 ,pp. : 2021-2041

Informa Healthcare

Access to resources Recommend Favorite

Predicting Treatment Response in Pediatric Anxiety Disorders

By  

Child and Adolescent Psychopharmacology News, Vol. 19, Iss. 5, 2014-10 ,pp. : 7-9

Guilford Publications Inc

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Pharmacotherapy for Anxiety Disorders in Children and Adolescents

By Hawkridge S.M.   Stein D.J.  

Drug Safety, Vol. 19, Iss. 4, 1998-10 ,pp. : 283-297

Adis International

Access to resources Recommend Favorite